Plasma Membrane Na+-Coupled Citrate Transporter (SLC13A5) and Neonatal Epileptic Encephalopathy
SLC13A5 is a Na+-coupled transporter for citrate that is expressed in the plasma membrane of specific cell types in the liver, testis, and brain. It is an electrogenic transporter with a Na+:citrate3− stoichiometry of 4:1. In humans, the Michaelis constant for SLC13A5 to transport citrate is ~600 μM...
Main Authors: | Yangzom D. Bhutia, Jonathan J. Kopel, John J. Lawrence, Volker Neugebauer, Vadivel Ganapathy |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/22/3/378 |
Similar Items
-
The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond
by: Rami Mosaoa, et al.
Published: (2021-01-01) -
NaCT/SLC13A5 facilitates citrate import and metabolism under nutrient-limited conditions
by: Avi Kumar, et al.
Published: (2021-09-01) -
Application of citrate as a tricarboxylic acid (TCA) cycle intermediate, prevents diabetic-induced heart damages in mice
by: Qianqian Liang, et al.
Published: (2016-01-01) -
Biochemical and Metabolic Implications of Tricarboxylic Acids and their Transporters
by: Khalifa El-Dawy, et al.
Published: (2019-06-01) -
Novel Human Polymorphisms Define a Key Role for the SLC26A6-STAS Domain in Protection From Ca2+-Oxalate Lithogenesis
by: Liana Shimshilashvili, et al.
Published: (2020-04-01)